慢性肢体威胁性缺血患者外周血管介入后主要不良肢体事件的黑人与拉丁裔种族差异在调整就诊时肢体威胁严重程度后仍持续存在
基于血管质量倡议外周血管介入数据集(2016-2021年)纳入47,830例有WIfI分期的慢性肢体威胁性缺血患者,分析1年主要不良肢体事件(MALE)。调整WIfI分期及医院变异和死亡竞争风险后,黑人(SHR 1.12;95%CI 1.01-1.25;P=.028)和拉丁裔(SHR 1.34;95%CI 1.16-1.54;P<.001)相较于白人仍有更高的MALE风险。结论提示就诊时疾病严重程度不能解释结局差异。
要点
- 白人、黑人、拉丁裔患者1年未调整MALE累积发生率分别为13.1%、14.3%、17.0%。
- 仅调整WIfI分期后,黑人SHR 1.12(95%CI 1.01-1.25;P=.028),拉丁裔SHR 1.34(95%CI 1.16-1.54;P<.001)。
- WIfI分期越高及干预平面越远端,1年MALE累积发生率越高。
核心结论
- 黑人和拉丁裔患者在外周血管介入治疗慢性肢体威胁性缺血后,相较白人患者具有更高的1年主要不良肢体事件风险,且该差异在调整就诊时WIfI分期后仍持续存在。
- 作者认为就诊时疾病严重程度不能解释结局差异,未来工作应聚焦于更好地理解历史上被边缘化种族和族裔群体慢性肢体威胁性缺血结局差异的潜在机制。
研究设计与样本
- 回顾性队列研究,查询血管质量倡议外周血管介入数据集(2016-2021年)中慢性肢体威胁性缺血患者,排除缺失WIfI分期者,最终纳入47,830例(占60%)有WIfI评分报告的患者(白人73%、黑人20%、拉丁裔7%)。
- 主要终点为1年主要不良肢体事件发生率,定义为主要截肢(经胫骨或腓骨或更近端)或初始治疗肢体的再干预(血管内或外科)。
- 采用多变量分层Fine-Gray分析,控制医院变异、死亡竞争风险和就诊时WIfI分期,评估黑人/非洲裔美国种族和拉丁裔/西班牙裔族裔与MALE的独立关联;采用Cox比例风险回归模型进行1年生存分析。
主要发现
- 1年未调整MALE累积发生率:白人13.1%(95%CI 12.6%-13.5%),黑人14.3%(95%CI 13.5%-15.3%),拉丁裔17.0%(95%CI 15.3%-18.9%)。
- 双变量分析显示MALE发生与较年轻年龄、黑人种族、拉丁裔族裔、冠状动脉疾病、脑血管疾病、充血性心力衰竭、高血压、糖尿病、透析、干预平面、任何既往小或大截肢及WIfI分期显著相关(P<.001)。
- 1年MALE累积发生率随WIfI分期增加而升高:1期11.7%(95%CI 10.9%-12.4%),2期12.4%(95%CI 11.8%-13.0%),3期14.8%(95%CI 13.8%-15.8%),4期15.4%(95%CI 14.3%-16.6%)。
- 1年MALE累积发生率随干预平面增加而升高:流入道10.7%(95%CI 9.8%-11.7%),股腘动脉12.3%(95%CI 11.7%-12.9%),膝下动脉14.1%(95%CI 13.5%-14.8%)。
- 仅调整WIfI分期后,黑人种族(SHR 1.30;95%CI 1.17-1.44;P<.001)和拉丁裔族裔(SHR 1.58;95%CI 1.37-1.81;P<.001)相较白人种族与1年MALE风险增加相关;多变量调整后,黑人/非洲裔美国种族(SHR 1.12;95%CI 1.01-1.25;P=.028)和拉丁裔/西班牙裔族裔(SHR 1.34;95%CI 1.16-1.54;P<.001)相较白人种族MALE差异仍持续存在。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Racial and ethnic disparities have been well-documented in the outcomes for chronic limb threatening ischemia (CLTI). One purported explanation has been the disease severity at presentation. We hypothesized that the disparities in major adverse limb events (MALE) after peripheral vascular intervention (PVI) for CLTI would persist despite controlling for disease severity at presentation using the WIfI (Wound, Ischemia, foot Infection) stage. METHODS: The Vascular Quality Initiative PVI dataset (2016-2021) was queried for CLTI. Patients were excluded if they were missing the WIfI stage. The primary end point was the incidence of 1-year MALE, defined as major amputation (through the tibia or fibula or more proximally) or reintervention (endovascular or surgical) of the initial treatment limb. A multivariate hierarchical Fine-Gray analysis was performed, controlling for hospital variation, competing risk of death, and presenting WIfI stage, to assess the independent association of Black/African American race and Latinx/Hispanic ethnicity with MALE. A Cox proportional hazard regression model was used for the 1-year survival analysis. RESULTS: Overall, 47,830 patients (60%) had had WIfI scores reported (73% White, 20% Black, and 7% Latinx). The 1-year unadjusted cumulative incidence of MALE was 13.1% (95% confidence interval [CI], 12.6%-13.5%) for White, 14.3% (95% CI, 13.5%-15.3%) for Black, and 17.0% (95% CI, 15.3%-18.9%) for Latinx patients. On bivariate analysis, the occurrence of MALE was significantly associated with younger age, Black race, Latinx ethnicity, coronary artery disease, cerebrovascular disease, congestive heart failure, hypertension, diabetes, dialysis, intervention level, any prior minor or major amputation, and WIfI stage (P < .001). The cumulative incidence of 1-year MALE increased by increasing WIfI stage: stage 1, 11.7% (95% CI, 10.9%-12.4%); stage 2, 12.4% (95% CI, 11.8%-13.0%); stage 3, 14.8% (95% CI, 13.8%-15.8%); and stage 4, 15.4% (95% CI, 14.3%-16.6%). The cumulative incidence also increased by intervention level: inflow, 10.7% (95% CI, 9.8%-11.7%), femoropopliteal, 12.3% (95% CI, 11.7%-12.9%); and infrapopliteal, 14.1% (95% CI, 13.5%-14.8%). After adjustment for WIfI stage only, Black race (subdistribution hazard ratio [SHR], 1.30; 95% CI, 1.17-1.44; P < .001) and Latinx ethnicity (SHR, 1.58; 95% CI, 1.37-1.81; P < .001) were associated with an increased 1-year hazard of MALE compared with White race. On adjusted multivariable analysis, MALE disparities persisted for Black/African American race (SHR, 1.12; 95% CI, 1.01-1.25; P = .028) and Latinx/Hispanic ethnicity (SHR, 1.34; 95% CI, 1.16-1.54; P < .001) compared with White race. CONCLUSIONS: Black/African American and Latinx/Hispanic patients had a higher associated hazard of MALE after PVI for CLTI compared with White patients despite an adjustment for WIfI stage at presentation. These results suggest that disease severity at presentation does not account for disparities in outcomes. Further work should focus on better understanding the underlying mechanisms for disparities in historically marginalized racial and ethnic groups presenting with CLTI.
引用
- Jaramillo EA, Smith EJT, Matthay ZA, et al. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention. J Vasc Surg. 2022. PMID: 36334848. doi:10.1016/j.jvs.2022.10.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。